Confirmed Partners & Exhibitors

Exhibit & Sponsorship Opportunities
Confirmed Partners
Confirmed Exhibitors

WTC 2025 Partners and Sponsors

WTC 2025 Congress offers a unique opportunity to market to an international multidisciplinary event of researchers, clinicians, health professionals and patient advocates in the field of research and management.

WTC 2025 Organizing Committee would like to thank the following companies for their support:

Diamond Level

Natera provides advanced DNA technology that enables transplant providers to deliver quality, personalized care. As a diagnostics company with proprietary bioinformatics and molecular technology, we’ve performed more than 10 million cfDNA tests and are dedicated to improving kidney, heart and lung care for good. Learn more at natera.com/organ-health.

Silver Level

At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. We ushered in the first new class of complement medicine in 15 years, and now have two approved medicines targeting C3, the central protein in the cascade. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world. Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.

Bridge to Life Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW®, EasiSlush® and the VitaSmart Hypothermic Oxygenated Perfusion System. With a strong focus on product quality, innovation and accessibility, the company serves and partners with leading Transplant Centers and Organ Procurement Offices globally.

IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.

Founded in 1998, XVIVO is the only MedTech company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. XVIVO’s innovative technologies enable clinicians and researchers around the world to preserve, transport and assess organs outside the body. Our pioneering technologies have been clinically proven to increase utilization of donated organs and improve transplantation outcomes. (www.xvivogroup.com)

Platinum Level

TransMedics is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the Organ Care System, or the OCS, to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide. Our innovative OCS technology replicates many aspects of the organ’s natural living and functioning environment outside of the human body. As such, the OCS represents a paradigm shift that transforms organ preservation for transplantation from a static state to a dynamic environment that enables new capabilities, including organ optimization and assessment.

Bronze Level

ALS engineers innovative and agile protective solutions targeting the key molecular pathways implicated in IRI. By protecting organs from IRI, ALS optimizes graft function recovery throughout the transplantation journey thereby improving patients’ survival and outcomes.

From the success of LifePort Kidney Transporter, Organ Recovery Systems introduces the next generation of preservation with the upcoming launch of the LifePort Liver Transporter. In addition to providing innovative products, ORS delivers support via the LifePort mobile app, 24/7 Perfusion Helpline, Instructor-Led Training, and online Client Community.

Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care. Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.